Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
FAQ
- What is Ionis Pharmaceuticals's EBIT?
- Ionis Pharmaceuticals (IONS) reported EBIT of -$102.29M in Q2 2026.
- How has Ionis Pharmaceuticals's EBIT changed year-over-year?
- Ionis Pharmaceuticals's EBIT decreased by 173.2% year-over-year, from $139.82M to -$102.29M.
- What is the long-term trend for Ionis Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's EBIT has grown at a 88.6% compound annual growth rate (CAGR), from -$30.19M to -$381.69M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Ionis Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude